|
US7592348B2
(en)
|
2003-12-15 |
2009-09-22 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7700603B2
(en)
|
2003-12-15 |
2010-04-20 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
CA2578600A1
(en)
|
2004-06-16 |
2006-01-26 |
Wyeth |
Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
|
|
CA2579724A1
(en)
|
2004-06-16 |
2006-01-26 |
Wyeth |
Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
|
|
BRPI0516132A
(pt)
*
|
2004-10-07 |
2007-12-04 |
Vitae Pharmaceuticals Inc |
compostos, composição destes, método de antagonização de uma ou mais proteases aspárticas e método para tratar ou melhorar um distúrbio mediado por protease aspártica
|
|
CN101103034A
(zh)
|
2005-01-14 |
2008-01-09 |
惠氏公司 |
抑制β-分泌酶的氨基-咪唑酮
|
|
EP1844035A1
(en)
|
2005-02-01 |
2007-10-17 |
Wyeth |
Amino-pyridines as inhibitors of beta-secretase
|
|
AU2006214627A1
(en)
|
2005-02-14 |
2006-08-24 |
Wyeth |
Azolylacylguanidines as beta-secretase inhibitors
|
|
EP1896406A2
(en)
*
|
2005-06-14 |
2008-03-12 |
Shering Corporation |
The preparation and use of compounds as protease inhibitors
|
|
WO2006138264A2
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Aspartyl protease inhibitors
|
|
CA2609562A1
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Macrocyclic heterocyclic aspartyl protease inhibitors
|
|
US7759353B2
(en)
*
|
2005-06-14 |
2010-07-20 |
Schering Corporation |
Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment
|
|
US8722708B2
(en)
|
2005-06-14 |
2014-05-13 |
Merck Sharp & Dohme Inc. |
Substituted isoindolines as aspartyl protease inhibitors
|
|
ATE482214T1
(de)
|
2005-06-14 |
2010-10-15 |
Schering Corp |
Aspartylproteasehemmer
|
|
BRPI0613578A2
(pt)
*
|
2005-06-30 |
2012-01-17 |
Wyeth Corp |
composito da fórmula i; uso de um composto de fórmula i; e composição farmacêutica
|
|
TW200738683A
(en)
|
2005-06-30 |
2007-10-16 |
Wyeth Corp |
Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
|
|
TW200730523A
(en)
*
|
2005-07-29 |
2007-08-16 |
Wyeth Corp |
Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
|
|
RU2008106936A
(ru)
|
2005-09-26 |
2009-11-10 |
Вайет (Us) |
Соединения амино-5-[4-(дифторметокси)фенил]-5-фенилимидазолона для ингибирования бета-секретазы
|
|
ES2537898T3
(es)
|
2005-10-25 |
2015-06-15 |
Shionogi & Co., Ltd. |
Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
|
|
CN101296926A
(zh)
|
2005-10-27 |
2008-10-29 |
先灵公司 |
天冬氨酰蛋白酶抑制剂
|
|
CN101351460A
(zh)
|
2005-10-31 |
2009-01-21 |
先灵公司 |
天冬氨酰蛋白酶抑制剂
|
|
WO2007058580A1
(en)
*
|
2005-11-15 |
2007-05-24 |
Astrazeneca Ab |
Novel 2-aminopyrimidinone derivatives and their use
|
|
TW200734311A
(en)
*
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
|
CN101360716A
(zh)
*
|
2005-11-21 |
2009-02-04 |
阿斯利康(瑞典)有限公司 |
新颖的2-氨基-咪唑-4-酮化合物及其在制备用于治疗认知缺损、阿尔茨海默病、神经变性和痴呆的药物中的用途
|
|
JP2009520027A
(ja)
*
|
2005-12-19 |
2009-05-21 |
ワイス |
2−アミノ−5−ピペリジニルイミダゾロン化合物およびβ−セクレターゼ調節におけるその使用
|
|
AR058381A1
(es)
*
|
2005-12-19 |
2008-01-30 |
Astrazeneca Ab |
Compuestos derivados de 2-aminopiridin-4-onas y una composicion farmaceutica
|
|
WO2007100536A1
(en)
|
2006-02-24 |
2007-09-07 |
Wyeth |
DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
|
|
JP5191155B2
(ja)
*
|
2006-03-27 |
2013-04-24 |
大塚製薬株式会社 |
カルボスチリル化合物からなる医薬
|
|
JP2009532464A
(ja)
*
|
2006-04-05 |
2009-09-10 |
アストラゼネカ・アクチエボラーグ |
2−アミノピリミジン−4−オン及びAβ−関連の病理を治療又は予防するためのその使用
|
|
CA2653650A1
(en)
*
|
2006-06-12 |
2007-12-21 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
TW200815349A
(en)
|
2006-06-22 |
2008-04-01 |
Astrazeneca Ab |
New compounds
|
|
US7700606B2
(en)
|
2006-08-17 |
2010-04-20 |
Wyeth Llc |
Imidazole amines as inhibitors of β-secretase
|
|
WO2008063114A1
(en)
*
|
2006-11-20 |
2008-05-29 |
Astrazeneca Ab |
Amino- imidazolones and their use as medicament for treating cognitive impairment alzheimer disease, neurodegeneration and dementia
|
|
MX2009006228A
(es)
*
|
2006-12-12 |
2009-06-22 |
Schering Corp |
Inhibidores de aspartil proteasa.
|
|
TW200831484A
(en)
*
|
2006-12-20 |
2008-08-01 |
Astrazeneca Ab |
New compounds
|
|
TW200831091A
(en)
*
|
2006-12-20 |
2008-08-01 |
Astrazeneca Ab |
New compounds
|
|
WO2008076043A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Astrazeneca Ab |
Novel 2-amino-5,5-diaryl-imidazol-4-ones
|
|
PE20090617A1
(es)
|
2007-03-23 |
2009-05-08 |
Wyeth Corp |
Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
|
|
EP2151435A4
(en)
|
2007-04-24 |
2011-09-14 |
Shionogi & Co |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
AU2008245082B8
(en)
|
2007-04-24 |
2012-09-13 |
Shionogi & Co., Ltd. |
Aminodihydrothiazine derivatives substituted with a cyclic group
|
|
TW200902503A
(en)
*
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
|
CN101848897A
(zh)
|
2007-09-06 |
2010-09-29 |
先灵公司 |
γ分泌酶调节剂
|
|
US8487099B2
(en)
|
2007-11-05 |
2013-07-16 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
WO2009076352A1
(en)
|
2007-12-11 |
2009-06-18 |
Schering Corporation |
Gamma secretase modulators
|
|
BRPI0906962B8
(pt)
|
2008-01-18 |
2021-05-25 |
Eisai R&D Man Co Ltd |
composto de aminodiidrotiazina fundido
|
|
AU2009239536C1
(en)
|
2008-04-22 |
2012-12-13 |
Merck Sharp & Dohme Corp. |
Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
|
|
US8637504B2
(en)
|
2008-06-13 |
2014-01-28 |
Shionogi & Co., Ltd. |
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
|
|
AU2009277485B2
(en)
|
2008-07-28 |
2013-05-02 |
Eisai R&D Management Co., Ltd. |
Spiroaminodihydrothiazine derivatives
|
|
WO2010013302A1
(ja)
*
|
2008-07-28 |
2010-02-04 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スピロアミノジヒドロチアジン誘導体
|
|
US8450308B2
(en)
|
2008-08-19 |
2013-05-28 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of beta-secretase
|
|
MX2011002705A
(es)
|
2008-09-11 |
2011-09-09 |
Amgen Inc |
Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
|
|
KR20110076965A
(ko)
|
2008-09-30 |
2011-07-06 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
신규한 축합 아미노 디하이드로티아진 유도체
|
|
WO2010047372A1
(ja)
|
2008-10-22 |
2010-04-29 |
塩野義製薬株式会社 |
Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体
|
|
JP5503663B2
(ja)
|
2008-11-13 |
2014-05-28 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ガンマセクレターゼモジュレータ
|
|
TW201020244A
(en)
|
2008-11-14 |
2010-06-01 |
Astrazeneca Ab |
New compounds
|
|
WO2010105179A2
(en)
*
|
2009-03-13 |
2010-09-16 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of beta-secretase
|
|
US20120015961A1
(en)
|
2009-03-31 |
2012-01-19 |
Shionogi & Co., Ltd. |
Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity
|
|
EP2443118A1
(en)
|
2009-06-16 |
2012-04-25 |
Schering Corporation |
Gamma secretase modulators
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
EP2281824A1
(en)
|
2009-08-07 |
2011-02-09 |
Noscira, S.A. |
Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
|
|
WO2011044185A2
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
WO2011044184A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
RU2012129168A
(ru)
|
2009-12-11 |
2014-01-20 |
Сионоги Энд Ко. Лтд. |
Производные оксазина
|
|
US20120245155A1
(en)
|
2009-12-11 |
2012-09-27 |
Shionogi & Co., Ltd. |
Fused heterocyclic compound having amino group
|
|
JP5828848B2
(ja)
*
|
2010-02-24 |
2015-12-09 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
ベータセクレターゼインヒビター
|
|
MX2012010658A
(es)
|
2010-03-15 |
2012-12-05 |
Amgen Inc |
Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
|
|
US8497264B2
(en)
|
2010-03-15 |
2013-07-30 |
Amgen Inc. |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
|
WO2012019056A1
(en)
|
2010-08-05 |
2012-02-09 |
Amgen Inc. |
Amino-iso-indole, amino-aza-iso-indole, amino-dihydroisoquinoline and amino-benzoxazine compounds as beta-secretase modulators and methods of use
|
|
US9018219B2
(en)
|
2010-10-29 |
2015-04-28 |
Shionogi & Co., Ltd. |
Fused aminodihydropyrimidine derivative
|
|
CA2816285A1
(en)
|
2010-10-29 |
2012-05-03 |
Shionogi & Co., Ltd. |
Naphthyridine derivative
|
|
US9284296B2
(en)
|
2010-11-22 |
2016-03-15 |
Aubergine Pharmaceuticals Llc |
Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
|
|
WO2012071279A1
(en)
|
2010-11-23 |
2012-05-31 |
Amgen Inc. |
Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
|
|
GB201100181D0
(en)
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
EP2665716B1
(en)
|
2011-01-21 |
2017-03-08 |
Eisai R&D Management Co., Ltd. |
Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
|
|
US9346827B2
(en)
|
2011-02-07 |
2016-05-24 |
Amgen Inc. |
5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
|
|
WO2012112462A1
(en)
|
2011-02-15 |
2012-08-23 |
Amgen Inc. |
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use
|
|
WO2012138734A1
(en)
|
2011-04-07 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2012147763A1
(ja)
|
2011-04-26 |
2012-11-01 |
塩野義製薬株式会社 |
オキサジン誘導体およびそれを含有するbace1阻害剤
|
|
RU2014111055A
(ru)
|
2011-08-22 |
2015-09-27 |
Мерк Шарп И Доум Корп. |
2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение
|
|
WO2013044092A1
(en)
|
2011-09-21 |
2013-03-28 |
Amgen Inc. |
Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
|
TWI557112B
(zh)
|
2012-03-05 |
2016-11-11 |
百靈佳殷格翰國際股份有限公司 |
β-分泌酶抑制劑
|
|
ES2745539T3
(es)
|
2012-03-19 |
2020-03-02 |
Buck Inst Res Aging |
Inhibidores de BACE específicos de APP (ASBI) y uso de los mismos
|
|
GB201209587D0
(en)
|
2012-05-30 |
2012-07-11 |
Takeda Pharmaceutical |
Therapeutic compounds
|
|
SG11201407796YA
(en)
|
2012-05-30 |
2014-12-30 |
Comentis Inc |
Chromane compounds
|
|
TW201422592A
(zh)
|
2012-08-27 |
2014-06-16 |
Boehringer Ingelheim Int |
β-分泌酶抑制劑
|
|
WO2014052398A1
(en)
|
2012-09-28 |
2014-04-03 |
Vitae Pharmaceuticals, Inc. |
Inhibitor of beta-secretase
|
|
EP2908825B1
(en)
|
2012-10-17 |
2018-04-18 |
Merck Sharp & Dohme Corp. |
Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
WO2014062553A1
(en)
|
2012-10-17 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
JP2016501827A
(ja)
|
2012-10-24 |
2016-01-21 |
塩野義製薬株式会社 |
Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
|
|
US9725469B2
(en)
|
2012-11-15 |
2017-08-08 |
Amgen, Inc. |
Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
|
|
US9489013B2
(en)
|
2012-12-20 |
2016-11-08 |
Merck Sharp & Dohme Corp. |
C6-azaspiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
US9580396B2
(en)
|
2012-12-21 |
2017-02-28 |
Merck Sharp & Dohme Corp. |
C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
|
|
EP3653609B1
(en)
|
2013-02-12 |
2024-04-03 |
Buck Institute for Research on Aging |
Hydantoins that modulate bace-mediated app processing
|
|
WO2014127881A1
(de)
|
2013-02-25 |
2014-08-28 |
Merck Patent Gmbh |
2-amino-3,4-dihydrc-chinazolin derivate und ihre verwendung als cathepsin d inhibitoren
|
|
AU2014223334C1
(en)
|
2013-03-01 |
2018-10-18 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
EP2964644B1
(en)
|
2013-03-08 |
2018-12-26 |
Amgen, Inc. |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
WO2014150340A1
(en)
|
2013-03-15 |
2014-09-25 |
Merck Sharp & Dohme Corp. |
S-imino-s-oxo iminothiadiazine compounds as bace inhibitors, compositions, and their use
|
|
US9422255B2
(en)
|
2013-03-15 |
2016-08-23 |
Merck Sharp & Dohme Corp. |
S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use
|
|
JP6401254B2
(ja)
*
|
2013-06-21 |
2018-10-10 |
武田薬品工業株式会社 |
プロキネシチン受容体のモジュレータとしての1−スルホニルピペリジン誘導体
|
|
EP3043802B1
(en)
|
2013-09-13 |
2018-04-18 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
CA2934257C
(en)
*
|
2013-12-17 |
2022-06-07 |
Janssen Pharmaceutica Nv |
Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer
|
|
EP3083575B1
(en)
|
2013-12-18 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
C-6 spirocarbocyclic iminothiadiazine dioxides as bace inhibitors, compositions, and their use
|
|
US9745324B2
(en)
|
2013-12-18 |
2017-08-29 |
Merck Sharp & Dohme Corp. |
Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
|
|
MX381482B
(es)
|
2014-08-08 |
2025-03-12 |
Amgen Inc |
Compuestos de tiazin-2-amina fusionados con ciclopropilo como inhibidores de beta-secretasa y metodos de uso.
|
|
JP6765681B2
(ja)
*
|
2015-04-21 |
2020-10-07 |
オールジェネシス バイオセラピューティクス インコーポレイテッド |
Bace1阻害剤としての化合物およびそれらの使用
|
|
CN105175488A
(zh)
*
|
2015-09-07 |
2015-12-23 |
西北农林科技大学 |
一种具有抗老年痴呆症活性的化合物及其制备方法
|
|
CN106749033A
(zh)
*
|
2015-11-25 |
2017-05-31 |
中国人民解放军军事医学科学院毒物药物研究所 |
乙内酰脲类化合物及其作为β-分泌酶抑制剂的用途
|
|
CA3005809A1
(en)
*
|
2015-11-25 |
2017-06-01 |
Ucb Biopharma Sprl |
Iminotetrahydropyrimidinone derivatives as plasmepsin v inhibitors
|
|
GB201603104D0
(en)
|
2016-02-23 |
2016-04-06 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
JP6504106B2
(ja)
*
|
2016-04-21 |
2019-04-24 |
三菱電機ビルテクノサービス株式会社 |
エレベータ装置
|
|
AU2017311691B2
(en)
|
2016-08-18 |
2021-12-02 |
Vidac Pharma Ltd. |
Piperazine derivatives, pharmaceutical compositions and methods of use thereof
|
|
CN107892697B
(zh)
|
2016-12-26 |
2020-11-03 |
郑州泰基鸿诺医药股份有限公司 |
一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
|
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
|
GB201805816D0
(en)
|
2018-04-06 |
2018-05-23 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
TW202104210A
(zh)
|
2019-04-17 |
2021-02-01 |
美商基利科學股份有限公司 |
Hiv蛋白酶抑制劑
|
|
GB201906804D0
(en)
|
2019-05-14 |
2019-06-26 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
WO2021026884A1
(en)
|
2019-08-15 |
2021-02-18 |
Merck Sharp & Dohme Corp. |
Antimalarial agents
|
|
US20220289685A1
(en)
|
2019-08-19 |
2022-09-15 |
UCB Biopharma SRL |
Antimalarial hexahydropyrimidine analogues
|
|
GB202010606D0
(en)
|
2020-07-10 |
2020-08-26 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
CN112010836B
(zh)
*
|
2020-09-07 |
2021-07-09 |
南通大学 |
含芳基联吡啶氧基结构的2-取代基咪唑烷衍生物及其制备方法和用途
|
|
EP4263524A1
(en)
|
2020-12-21 |
2023-10-25 |
Cytokinetics, Inc. |
Pyrazole derivatives useful as nampt modulators
|
|
GB202104097D0
(en)
*
|
2021-03-24 |
2021-05-05 |
Almac Discovery Ltd |
Pharmaceutical compounds
|
|
EP4476201A1
(en)
|
2022-02-08 |
2024-12-18 |
UCB Biopharma SRL |
Antimalarial hexahydropyrimidine analogues
|